HDV
The summaries are free for public use. The Chronic Liver Disease Foundation will continue to add and archive summaries of articles deemed relevant to CLDF by the Board of Trustees and its Advisors.
Bulevirtide Monotherapy or in Combination for Chronic Hepatitis Delta: 2025 Update.
Lampertico Pietro (P);Anolli Maria Paola (MP);Steppich Katja (K);Wedemeyer Heiner (H)
Ten-Year Follow-Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT-II): Improved Clinical Outcome After Combination Therapy.
Yurdaydin Cihan (C);Kahlhöfer Julia (J);Caruntu Florin Alexandru (FA);Yalcin Kendal (K);Gürel Selim (S);Akarca Ulus S (US);Sprinzl Kathrin (K);Bock Hans H (HH);Bockmann Jan-Hendrik (JH);Papatheodoridis George V (GV);Merle Uta (U);Demir Münevver (M);Hardtke Svenja (S);Keskin Onur (O);Idilman Ramazan (R);Cornberg Markus (M);Wedemeyer Heiner (H);Wranke Anika (A)
A Collection of Patient-Derived Intestinal Organoid Lines Reveals Epithelial Phenotypes Associated with Genetic Drivers of Pediatric Inflammatory Bowel Disease.
Shojaei Jeshvaghani Zahra (Z);Argmann Carmen (C);de Vries Maaike H (MH);van Es Johan H (JH);Collen Lauren V (LV);Kotlarz Daniel (D);Sveen Mia (M);Comella Phillip H (PH);Snapper Scott B (SB);Klein Christoph (C);Schadt Eric E (EE);Clevers Hans (H);Mokry Michal (M);Kuijk Ewart (E);Nieuwenhuis Edward (E)
Evaluation of HDV stability under different biological sample collection and storage conditions: implications for molecular diagnosis.
Queiroz Jackson Alves da Silva (JADS);Arruda Mônica Barcellos (MB);Roca Tárcio Peixoto (TP);Araújo Adrhyan (A);Passos-Silva Ana Maísa (AM);de Castro E Silva Eugênia (E);Borzacov Lourdes Maria Pinheiro (LMP);Calazans Alexandre Rodrigues (AR);Salcedo Juan Miguel Villalobos (JMV);Baptista Patrícia Alvarez da Silva (PADS);Vieira Deusilene (D)
Hepatitis Vaccines: Recent Advances and Challenges.
Lu Mei (M);Liu Yakun (Y);Li Lele (L);Liu Xueke (X);Wu Bin (B);Wu Yingping (Y)
Bulevirtide for chronic hepatitis delta: from clinical trials to real life data: an expert opinion report.
Asselah Tarik (T);Razavi Homie (H);Fontaine Hélène (H);Agarwal Kosh (K)
SOLSTICE: tobevibart plus elebsiran for hepatitis D.
Ray Katrina (K)
Rigorous quantum calculations for atom-molecule chemical reactions in electric fields: From single to multiple partial wave regimes.
Tscherbul Timur V (TV);Krems Roman V (RV)
High hepatitis B exposure and HIV prevalence but no evidence of HDV among Haitian migrants in Chile: A cross-sectional study.
Uribe Javier (J);Pérez-Valenzuela Javier (J);Astudillo Patricio (P);Vargas José Ignacio (JI);Benítez Carlos (C);López-Lastra Marcelo (M);Núñez Ruth (R);Soza Jacinta (J);Pino Karla (K);Fuster Francisco (F);Soza Alejandro (A)
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D.
Asselah Tarik (T);Chattergoon Michael A (MA);Jucov Alina (A);Streinu-Cercel Anca (A);Lampertico Pietro (P);Wedemeyer Heiner (H);Kennedy Patrick T (PT);Gane Edward J (EJ);Bullard Brianna L (BL);Chow Sophia (S);Santos Desiree (D);Camus Gregory (G);Lu Yimeng (Y);Pilowa Cara (C);Hwang Carey (C);Correll Todd (T);Agarwal Kosh (K); ()
Hepatitis D virus infection prevalence in persons with human immunodeficiency virus and hepatitis B virus coinfection in Germany.
Elamouri Fauzi (F);Lutz Thomas (T);Knecht Gabi (G);Wyen Christoph (C);Posdzich Philip (P);Monin Malte (M);Sabranski Michael (M);Hoffmann Christian (C);Killer Alexander (A);Jensen Björn Erik-Ole (BE);Malin Jakob J (JJ);Esser Stefan (S);Mauss Stefan (S);Vogelmann Roger (R);Boesecke Christoph (C);Beer Daniel (D);Grunwald Stephan (S);Haberl Annette (A);Voit Florian (F);Qurishi Nazifa (N);Noe Sebastian (S);Khaykin Pavel (P);Schneeweiß Stephan M (SM);Christensen Stefan (S);Schwarze-Zander Carolynne (C);Jessen Arne (A);Boyd Anders (A);Rockstroh Jürgen K (JK);van Bremen Kathrin (K)
Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program.
Stern Christiane (C);Loustaud-Ratti Véronique (V);Yurdaydin Cihan (C);Brancaccio Giuseppina (G);Jachs Mathias (M);Reiberger Thomas (T);Bardou-Jacquet Edouard (E);Metivier Sophie (S);Alric Laurent (L);Colombain Lea (L);Meszaros Magdalena (M);Mathurin Philippe (P);Yardeni David (D);Etzion Ohad (O);Neumann-Haefelin Christoph (C);Douglas Mark (M);Poulin Sébastien (S);Bazinet Michel (M);Metin R Olga (RO);Vitale Alessandro (A);Gaeta Giovanni Battista (GB);Schwarz Michael (M);Ben-Ali Souad (S);Bedoya Jose Ursic (JU);Testoni Barbara (B);Zoulim Fabien (F);Plissonnier Marie-Laure (ML);Levrero Massimo (M);Paradis Valerie (V);Francois Sandrine (S);de Freitas Cecilia (C);Kaysin Furkan (F);Lecomte Laurence (L);Morvan Christopher (C);Schramko Jocelyn (J);Bondezi Kindness (K);Baril Marie-Éve (MÉ);Brichler Ségolène (S);Gerber Athenaïs (A);Gordien Emmanuel (E);Mackiewicz Vincent (V);Dahari Harel (H);Svicher Valentina (V);Chevaliez Stéphane (S);Vaillant Andrew (A);Bourliere Marc (M)
Prevalence of hepatitis D among patients with hepatitis B: A cross-sectional study.
Domudala Rachana (R);Prasanna Sridevi (S);Yelamanchili Sadhana (S);Venishetty Shantan (S);Alla Manasa (M);Iyengar Sowmya (S);Sharma Mithun (M);Rao Padaki Nagaraja (PN);Reddy D N (DN);Kulkarni Anand V (AV)
AASLD/IDSA Practice Guideline on treatment of chronic hepatitis B.
Ghany Marc G (MG);Pan Calvin Q (CQ);Lok Anna S (AS);Feld Jordan J (JJ);Lim Joseph K (JK);Wang Su H (SH);Kim Arthur Y (AY);Tang Amy S (AS);Nguyen Mindie H (MH);Naggie Susanna (S);Sulkowski Mark S (MS);Rodriguez-Baez Norberto (N);Chen J (J);Murad M Hassan (MH);Mohammad Khaled S (KS);Terrault Norah A (NA)
Technical systematic review supporting the 2025 AASLD Practice Guideline on management of chronic hepatitis B.
Pan Calvin Q (CQ);Saadi Samer (S);Ghany Marc G (MG);Feld Jordan J (JJ);Lim Joseph K (JK);Kim Arthur Y (AY);Tang Amy S (AS);Nguyen Mindie H (MH);Sulkowski Mark S (MS);Terrault Norah A (NA);Lok Anna S (AS);Hegazi Moustafa (M);Hasan Bashar (B);Fleti Farah (F);Nayfeh Tarek (T);Abusalih Mohamed F (MF);Seisa Mohamed O (MO);Kabbara Allababidi Adel (A);Abbas Alzhraa S (AS);Prokop Larry J (LJ);Murad M Hassan (MH);Mohammad Khaled S (KS)
The Challenge of Hepatitis D Virus Coinfection in Iran: Age, Access, and Unanswered Public Health Questions.
Byeon Haewon (H)
The Complex Interplay of Hepatitis D in Patients with Hepatitis B: Letter to the Editor.
Bagheri Lankarani Kamran (K)
Therapies and Pipeline for Hepatitis B and Hepatitis D.
Lee James (J);Shah Nishali (N);Kukreja Rahul (R);Vemulapalli Bhargav (B);Rustgi Vinod (V)